Takeda has received approval from the European Commission (EC) for its Pfizer-partnered blood cancer drug Adcetris (brentuximab vedotin). The drug has been approved in combination with the ...

This trial started in 2014 and these results were published in 2016. Researchers wanted to find out whether nivolumab helped people with Hodgkin lymphoma that had come back after a stem cell ...

Non-Hodgkin lymphoma is a cancer that affects lymphocytes, a type of white blood cells in the lymphatic system. They are generally classified according to the cancer's growth rate as high grade ...

The treatment for non-Hodgkin lymphoma depends on several factors. These include the number and places in the body that are affected by ... share experiences, and get support. Cancer Chat is free to ...

Magda Szubanski diagnosed with mantle cell lymphoma: What you must know about disease. Beloved TV icon Magda Szubanski’s diagnosis has thrown the spotlight on a rare type of blood cancer.

Kite Pharma’s bicistronic CAR T-cell therapy hit the main goal of a phase 1a trial, with zero dose-limiting toxicities (DLTs) occurring in patients with advanced B-cell lymphoma (BCL).

Non-Hodgkin Lymphoma Risk Factors. American Cancer Society. September 19, 2022. Tests for Non-Hodgkin Lymphoma. American Cancer Society. August 1, 2018. Non-Hodgkin Lymphoma Stages. American ...

Makaila Chenier, 17, from Texas, brushed off a common cold symptom millions of people suffer from. She had no idea it was actually cancer.

In a video posted to Instagram, the 64-year-old said the Mantle Cell Lymphoma is a rare and fast-moving form of blood cancer. Szubanski will soon begin treatment with the Nordic protocol.

Mantle cell lymphoma is a rare, aggressive type of non-Hodgkin lymphoma arising from malignant B cells in the mantle zone of lymph nodes. It accounts for about 5% of lymphoma cases, is more common ...

Mantle cell lymphoma is one of about 60 sub-types of non-Hodgkin lymphoma, the Cancer Council's website says. Szubanski says she is surrounded by "beautiful friends and family and an incredible ...

Takeda (NYSE:TAK) (4502.T) said on Monday that the European Commission approved Pfizer (NYSE:PFE) and the company's antibody-drug conjugate, Adcetrix, in combination with a chemotherapy regimen in ...